SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Clinical trials for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA) trials appear
Sign up with your email to follow new studies for SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Milder transplant method aims to help young patients with rare blood diseases
Disease control Recruiting nowThis study is testing a less intense chemotherapy and radiation regimen before a stem cell transplant for children and young adults up to age 55 with non-cancerous blood disorders like immune deficiencies, anemias, and metabolic diseases. The goal is to see if this gentler prepar…
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Phase: PHASE2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
Real-world check: does ilaris work safely for rare fever diseases?
Disease control Recruiting nowThis study watches children and adults who are already taking or about to start Ilaris for hereditary periodic fever syndromes or systemic juvenile idiopathic arthritis. Researchers will track side effects and how well the drug controls symptoms over 16 weeks. No new medicine is …
Matched conditions: SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA)
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 09, 2026 12:07 UTC